Literature DB >> 6885173

Ticarcillin serum and tissue concentrations in gynecology and obstetrics.

D von Kobyletzki, A Dalhoff, H Lindemeyer, C A Primavesi.   

Abstract

Ticarcillin tissue concentrations were determined in 77 patients following an infusion of 5 g over 30 min. The tissues studied in gynecology were endometrium, tube, ovary and myometrium. The relative tissue levels ranged from 17% to 30% of the corresponding serum concentrations when ticarcillin was administered once, and from 22% to 32% when the drug was infused repeatedly. In no case did these tissue levels exceed the serum concentrations. The mean relative tissue levels in early pregnancy (decidua, placenta, embryo) were 10% of the corresponding serum concentrations. Levels in late pregnancy were determined in the placenta, amniotic fluid and in serum from the umbilical cord artery and vein immediately after delivery. Maximal placenta concentrations of 30 mg/kg were determined; these declined exponentionally with half-lives of 2.8 and 1.3 h, respectively, following single and repeated dosings. Amniotic fluid levels increased from 10 mg/l immediately after the first infusion to 60 mg/l after the seventh infusion. Individual umbilical cord levels in the artery and vein were significantly different, indicating that the fetus has properties of a deep compartment. The total amount of ticarcillin excreted daily in the mother's milk was strictly correlated to its volume and ranged from 2-2.5 mg/l.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885173     DOI: 10.1007/bf01641293

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  26 in total

1.  [On the pharmacokinetics of gentamycin. / Clinico-pharmacological study on the course of gentamycin concentrations in serum during large-volume infusions (author's transl)].

Authors:  S Kaumeier; P Lücker
Journal:  Arzneimittelforschung       Date:  1977

2.  Letter: Prolonged excretion of gentamicin in a patient with umimpaired renal function.

Authors:  G Kahlmeter; G Kamme
Journal:  Lancet       Date:  1975-02-01       Impact factor: 79.321

3.  Ticarcillin, a new semisynthetic penicillin active on Pseudomonas aeruginosa: in vitro activity and blood levels in man.

Authors:  J Klastersky; A Henri; D Daneau
Journal:  J Clin Pharmacol       Date:  1974-04       Impact factor: 3.126

4.  [Ticarcillin: in-vitro activity and pharmacokinetics (author's transl)].

Authors:  C Simon; M Leuth; V Malerczyk
Journal:  Dtsch Med Wochenschr       Date:  1974-11-29       Impact factor: 0.628

5.  [Bioavailability of chemotherapeutics in high-volume fluid therapy].

Authors:  A Dalhoff; P Koeppe; F Hulla
Journal:  Dtsch Med Wochenschr       Date:  1981-12-25       Impact factor: 0.628

6.  [Further pharmacokinetical observations on gentamicin (author's transl)].

Authors:  H Wahlig; G Langenberg; D von Kobyletzki
Journal:  Infection       Date:  1975       Impact factor: 3.553

7.  Pharmacokinetics of mezlocillin in healthy volunteers.

Authors:  T Bergan
Journal:  Antimicrob Agents Chemother       Date:  1978-12       Impact factor: 5.191

8.  Comparison between the pharmacokinetic properties of mezlocillin when given intravenously as a bolus injection or as an infusion.

Authors:  H Ohlsson; T Bergan
Journal:  Arzneimittelforschung       Date:  1979

9.  Elimination kinetics of mezlocillin in normal and impaired renal function including the effects of dialysis.

Authors:  J Kosmidis; P Doundoulaki; C Stathakis; N Zerefos; A Bounia; G K Daikos
Journal:  Arzneimittelforschung       Date:  1979

10.  Prediction of cefazolin penetration in high- and low-protein-containing extravascular fluid: new method for performing simultaneous studies.

Authors:  L R Peterson; D N Gerding
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.